ViPOR
Jun 21, 2024•14 min
Episode description
An experimental regimen for DLBCL piques my interest.
Venetoclax
ibrutinib
Prednisone
Obinutuzumab
Revlimid (lenalidomide)
Link: https://www.nejm.org/doi/pdf/10.1056/NEJMoa2401532
For the best experience, listen in Metacast app for iOS or Android
